Explore the Fingerprint Trends
Explore the Research Network
This is a list of publications by this organization, listed chronologically starting with the most recent first. The source of publications may be a combination of Scopus and manually entered data from a user. New publications from Scopus appear in this list weekly and publications entered by a user appear instantly. Citation counts start from 1996 and come directly from Scopus.
Ian M. Thompson; Stephen F. Kappa; Todd M. Morgan; Daniel A. Barocas; Carl J. Bischoff; Kirk A. Keegan; Kelly L. Stratton; Peter E. Clark; Matthew J. Resnick; Joseph A. Smith; et al.
Blood loss associated with radical cystectomy: A prospective, randomized study comparing Impact LigaSure vs. stapling device
Amir Goldkorn; Benjamin Ely; David I. Quinn; Catherine M. Tangen; Louis M. Fink; Tong Xu; Przemyslaw Twardowski; Peter J. Van Veldhuizen; Neeraj Agarwal; Michael A. Carducci; et al.
Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: A phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer
Jyoti D. Patel; Lada Krilov; Sylvia Adams; Carol Aghajanian; Ethan Basch; Marcia S. Brose; William L. Carroll; Marcos De Lima; Mark R. Gilbert; Mark G. Kris; et al.
Clinical cancer advances 2013: Annual report on progress against cancer from the American Society of Clinical Oncology
Catherine E. Dubeau; Stephen R. Kraus; Tomas L. Griebling; Diane K. Newman; Jean F. Wyman; Theodore M. Johnson II; Joseph G. Ouslander; Franklin Sun; Jason Gong; Tamara Bavendam
Effect of fesoterodine in vulnerable elderly subjects with urgency incontinence: A double-blind, placebo controlled trial
Christos S. Georgiades; Ron Rodriguez
Efficacy and Safety of Percutaneous Cryoablation for Stage 1A/B Renal Cell Carcinoma: Results of a Prospective, Single-Arm, 5-Year Study
H. Su; T. Xu; S. Ganapathy; M. Shadfan; M. Long; T.H.-M. Huang; I. Thompson; Z.-M. Yuan
Elevated snoRNA biogenesis is essential in breast cancer
Andrew J. Vickers; Daniel D. Sjoberg; David Ulmert; Emily Vertosick; Monique J. Roobol; Ian Thompson; Eveline A.M. Heijnsdijk; Harry De Koning; Coral Atoria-Swartz; Peter T. Scardino; et al.
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Donna P. Ankerst; Andreas Boeck; Stephen J. Freedland; J. Stephen Jones; Angel M. Cronin; Monique J. Roobol; Jonas Hugosson; Michael W. Kattan; Eric A. Klein; Freddie Hamdy; et al.
Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: Results from the prostate biopsy collaborative group
Mark A. Castanares; Amarnath Mukherjee; Wasim H. Chowdhury; Minzhi Liu; Ying Chen; Ronnie C. Mease; Yuchuan Wang; Ronald Rodriguez; Shawn E. Lupold; Martin G. Pomper
Evaluation of prostate-specific membrane antigen as an imaging reporter
Ian M. Thompson; Robin J. Leach; Donna P. Ankerst
Focusing PSA testing on detection of high-risk prostate cancers by incorporating patient preferences into decision making
Ian M. Thompson; April B. Cabang; Michael J. Wargovich
Future directions in the prevention of prostate cancer
Alberto Parra; Anand B. Karnad; Ian M. Thompson
Hispanic accrual on randomized cancer clinical trials: A call to arms
Demetrius Albanes; Cathee Till; Eric A. Klein; Phyllis J. Goodman; Alison M. Mondul; Stephanie J. Weinstein; Philip R. Taylor; Howard L. Parnes; J. Michael Gaziano; Xiaoling Song; et al.
Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin e Cancer Prevention Trial (SELECT)
Ramgopal Satyanarayana; Dipen Parekh
Prevention and treatment of biopsy-related complications
Svend O. Freytag; Hans Stricker; Mei Lu; Mohamed Elshaikh; Ibrahim Aref; Deepak Pradhan; Kenneth Levin; Jae Ho Kim; James Peabody; Farzan Siddiqui; et al.
Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer
James L. Leake; Rulon Hardman; Vijayanadh Ojili; Ian Thompson; Alampady Shanbhogue; Javier Hernandez; Jelle Barentsz
Prostate MRI: Access to and current practice of prostate MRI in the United States
Ian M. Thompson Jr.; Catherine M. Tangen; Phyllis J. Goodman
Re: Long-term survival of participants in the Prostate Cancer Prevention Trial
Edward A. Medina; Xiaoyu Shi; Marcia H. Grayson; Donna P. Ankerst; Carolina B. Livi; Maria V. Medina; Ian M. Thompson Jr.; Robin J. Leach
The diagnostic value of adiponectin multimers in healthy men undergoing screening for prostate cancer
August Blackburn; Desiree Wilson; Jonathan Gelfond; Li Yao; Javier Hernandez; Ian M. Thompson; Robin J. Leach; Donna M. Lehman
Validation of copy number variants associated with prostate cancer risk and prognosis
Anna Buteau; Casey A. Seideman; Robert S. Svatek; Ramy F. Youssef; Gaurab Chakrabarti; Gary Reed; Deepa Bhat; Yair Lotan
What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up